摘要
目的:比较后程加速超分割适形放疗(简称适形放疗)和适形放疗加同步化疗治疗食管癌的疗效与毒副反应。方法:将无远处转移的62例初治食管鳞癌患者随机分成适形放疗组和适形放疗协同化疗组(简称综合组)。适形放疗组:先行放疗41.4Gy/(23次.5周),后行放疗27Gy/(18次.2周);综合组:放射治疗方法同适形放疗组,只是在放射治疗的开始时同期均加用2个周期化疗(5-FU 0.75g,静脉滴入,1次/d,d1~d5;DDP 40mg,静脉滴入,1次/d,d1~d3),从放疗第1天开始,28d为1个周期。观察指标主要包括食管和肺的近期急性反应、后期放射损伤、血液学不良反应、1~5年局控率、无瘤生存率和总体生存率等。结果:综合组总生存率和无瘤生存率均高于适形放疗组,但差异无统计学意义,P>0.05。综合组的急性毒副反应较严重,Ⅲ级急性食管炎、骨髓抑制发生率与适形放疗组比较差异有统计学意义,P值分别为0.001和0.02。晚期并发症主要表现为食管狭窄和肺纤维化,两组比较差异无统计学意义。结论:后程加速超分割适形放疗加同步化疗治疗食管癌,患者能耐受,但其加重了急性反应,未加重远期毒副反应;能提高1~5年无瘤生存率和总体生存...
OBJECTIVE:To compare the treatment results and toxicities between the group of LCAHCR and the group of LCAHCR with chemotherapy.METHODS: Sixty-two patients with esophageal squanous cell carcinoma without distance relapse were randomized into two groups: patients in the group of LCAHCR received first stage radiation to a dose of 41.4 Gy/23 f in 5 weeks,and then received second stage radiation to a dose of 27 Gy/18 f2 weeks;Patients in the group of LCAHCR with chemotherapy received the same radiation as the g...
出处
《中华肿瘤防治杂志》
CAS
2008年第12期943-945,共3页
Chinese Journal of Cancer Prevention and Treatment
关键词
食管肿瘤/放射疗法
食管肿瘤/药物疗法
放射疗法
适形
预后
esophageal neoplasms/radiotherapy
esophageal neoplasms/drug therapy
radiotherapy
conformal
prognosis